We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
-3.48%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$195M
AUM Growth
+$72.8M
Cap. Flow
+$86.8M
Cap. Flow %
44.43%
Top 10 Hldgs %
56.45%
Holding
140
New
28
Increased
23
Reduced
31
Closed
32

Top Buys

Rank Stock Value
1
DELL icon
Dell
DELL
+$91.8M
2
WCG
Wellcare Health Plans, Inc.
WCG
+$2.76M
3
INVA icon
Innoviva
INVA
+$2.69M
4
AGN
Allergan plc
AGN
+$2.55M
5
BABA icon
Alibaba
BABA
+$2.54M

Top Sells

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$4.7M
2
BIIB icon
Biogen
BIIB
+$4.23M
3
ARRS
ARRIS International plc Ordinary Shares
ARRS
+$2.92M
4
IDTI
Integrated Device Technology I
IDTI
+$2.79M
5
LXFT
Luxoft Holding, Inc.
LXFT
+$2.69M

Sector Composition

Rank Sector Weight
1 Technology 48.76%
2 Healthcare 11.82%
3 Consumer Discretionary 9.1%
4 Communication Services 5.74%
5 Financials 4.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
51
Apple
AAPL
$4.57T
$633K 0.32%
12,800
+800
+7% +$39K
APH icon
52
Amphenol
APH
$209B
$633K 0.32%
26,400
+3,600
+16% +$86.6K
TXN icon
53
Texas Instruments
TXN
$261B
$631K 0.32%
5,500
+400
+8% +$44.7K
CHX
54
DELISTED
ChampionX
CHX
$624K 0.32%
+18,600
New +$675K
K
55
DELISTED
Kellanova
K
$616K 0.32%
12,248
-1,704
-12% -$90.5K
MO icon
56
Altria Group
MO
$114B
$616K 0.32%
13,000
+200
+2% +$10.5K
CNR
57
Core Natural Resources Inc
CNR
$4.45B
$615K 0.31%
23,100
– –
CARS icon
58
Cars.com
CARS
$660M
$578K 0.3%
29,300
– –
MRK icon
59
Merck
MRK
$318B
$528K 0.27%
+6,602
New +$506K
HCA icon
60
HCA Healthcare
HCA
$89.5B
$527K 0.27%
3,900
-1,000
-20% -$126K
UHS icon
61
Universal Health Services
UHS
$10.5B
$522K 0.27%
4,000
-800
-17% -$101K
LBTYK icon
62
Liberty Global Class C
LBTYK
$3.49B
$517K 0.26%
+19,500
New +$501K
AMGN icon
63
Amgen
AMGN
$222B
$516K 0.26%
+2,800
New +$501K
ELV icon
64
Elevance Health
ELV
$85.5B
$508K 0.26%
1,800
-300
-14% -$81.9K
REGN icon
65
Regeneron Pharmaceuticals
REGN
$80.8B
$501K 0.26%
1,600
+100
+7% +$33.3K
VIAB
66
DELISTED
Viacom Inc. Class B
VIAB
$499K 0.26%
16,700
-1,300
-7% -$38K
VZ icon
67
Verizon
VZ
$196B
$491K 0.25%
8,600
-600
-7% -$34.6K
PARA
68
DELISTED
Paramount Global Class B
PARA
$489K 0.25%
9,800
-900
-8% -$44.5K
TMUS icon
69
T-Mobile US
TMUS
$190B
$489K 0.25%
6,600
-800
-11% -$59.4K
IPG
70
DELISTED
Interpublic Group of Companies
IPG
$488K 0.25%
21,600
-1,900
-8% -$42.2K
UNH icon
71
UnitedHealth
UNH
$370B
$488K 0.25%
2,000
-500
-20% -$120K
JNJ icon
72
Johnson & Johnson
JNJ
$625B
$487K 0.25%
+3,500
New +$484K
TGT icon
73
Target
TGT
$68B
$442K 0.23%
5,100
-3,100
-38% -$250K
TSM icon
74
TSMC
TSM
$2.18T
$431K 0.22%
11,000
+500
+5% +$20.6K
NVR icon
75
NVR
NVR
$17B
$404K 0.21%
+120
New +$385K
1 2
3
4 5

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
RC
Reik & Co New York $363M AUM 3.03% 1-Year Est. Return
VIA
Virtus Investment Advisers Hartford, Connecticut $363M AUM 34.89% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $361M AUM 134.26% 1-Year Est. Return

HighVista Strategies's Q2 2019 Portfolio in Review

As of Q2 2019, HighVista Strategies held 140 positions worth $195M, up 59% from $123M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

HighVista Strategies deployed $86.8M of net new capital in Q2 2019, opening 28 new positions and adding to 23 existing holdings. Its largest new stake was Dell: 2,943,406 shares worth $75.8M.

By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Medicines Co, an estimated $4.7M trimmed.

  • HighVista Strategies's largest Q2 2019 buy was Dell: 2,943,406 shares worth $75.8M.
  • HighVista Strategies added most to Alibaba in Q2 2019, an estimated $2.54M increase.
  • HighVista Strategies's biggest Q2 2019 reduction was Medicines Co, cutting an estimated $4.7M.
  • HighVista Strategies fully exited ARRIS International plc Ordinary Shares in Q2 2019, selling an estimated $2.92M.
  • HighVista Strategies's ten largest holdings make up 56% of its $195M portfolio in Q2 2019.
  • HighVista Strategies opened 28 new positions and closed 32 in Q2 2019.
  • HighVista Strategies's portfolio value rose 59% quarter-over-quarter to $195M.

Based on HighVista Strategies's 13F filing for Q2 2019, filed 14 Aug 2019.